Sunavo Dasgupta, MD
Pain Management · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
- Since medical school
- 22 years
- Medical College of Wisconsin, 2004
Offices
1 location · Alameda Health System · 597 clinicians in this group
Hospitals listed: Highland Hospital. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dasgupta’s office at (510) 437-4800 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C171447 · Current
Licensed to practise in California · since 2021 · expires 2027-02-28 · Medical College of Wisconsin.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 036122789Licensed Physician And Surgeon · since 2009 · expires 2026-08-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Anesthesiology - Anesthesiology
- American Board of Anesthesiology - Pain Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Highland HospitalOakland, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.568, Oct 2024 – Sep 2025
See every measure and the patient survey for Highland Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 5 the same, 1 worse of 6 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.568 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 487 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.7 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.35 (145.43 to 251.26) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 83 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 68 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,143 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 4,370 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,344 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.54 (0.29 to 4.79) · 689 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.37 to 3.78) · 165 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.91 (0.34 to 3.48) · 681 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.62 (2.72 to 20.53) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.44 (1.37 to 9.5) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.97 (0.49 to 3.45) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.76 (0.07 to 1.44) · 3,387 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.519 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.682 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 51 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 141.8 · 59 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27.6 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.3 · 253 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 243 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.2 to 7.7) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (9.7 to 18.5) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 19.4) · 355 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,960 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$4,954
Medicare paid this office $4,954 for 33 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures year by year
| Procedure | 2017 | 2018 | 2019 | 2020 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 100 | 125 | 96 | 27 | – | – |
| Injection of trigger points, 3 or more muscles | 27 | 72 | 151 | 49 | – | – |
| Injection of substance into lower spine canal using imaging guidance | 75 | 84 | 98 | 36 | – | – |
| Aspiration and/or injection of fluid from large joint | 26 | 43 | 60 | 23 | – | – |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 37 | 29 | 32 | 17 | – | – |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 22 | 23 | 24 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
33 Original Medicare patients in 2024. Average age 70 · Health risk score 1.17. At or below the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 75% · Diabetes 45% · Depression 42%.
The office billed $38,585, Medicare allowed $7,152 and paid $4,954; for 64 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 33 | 64 | 70 | 1.17 | $38,585 | $4,954 |
| 2023 | 31 | 57 | 67 | 1.06 | $44,524 | $6,740 |
| 2020 | 246 | 2,052 | 72 | 1.46 | $613,234 | $83,548 |
| 2019 | 343 | 7,808 | 71 | 1.35 | $1,410,736 | $169,904 |
| 2018 | 312 | 8,910 | 71 | 1.40 | $1,548,002 | $188,437 |
| 2017 | 327 | 3,536 | 70 | 1.42 | $1,320,810 | $162,693 |
| 2016 | 369 | 4,543 | 71 | 1.52 | $1,447,448 | $168,058 |
| 2015 | 334 | 4,834 | 70 | 1.42 | $1,134,138 | $130,545 |
| 2014 | 335 | 4,541 | 70 | 1.35 | $1,353,636 | $132,031 |
| 2013 | 339 | 3,937 | 70 | 1.43 | $1,555,369 | $168,958 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2020: 21 services
| Short return visit (20+ min) | 118 | $9,825 | $58 |
| Injection of substance into lower spine canal using imaging guidance | 26 | $7,213 | $200 |
| Testing for presence of drug, by chemistry analyzers | 89 | $5,818 | $61 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 20 | $5,588 | $207 |
| New patient visit (45+ min) | 35 | $4,710 | $135 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 27 | $4,376 | $151 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 35 | $3,975 | $114 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 12 | $3,361 | $198 |
| Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | 55 | $3,347 | $45 |
| Return visit (30+ min) | 26 | $2,634 | $85 |
| Injection of trigger points, 3 or more muscles | 21 | $2,433 | $50 |
| Ultrasonic guidance for needle placement | 21 | $1,993 | $42 |
| Fluoroscopic guidance for needle placement | 13 | $1,923 | $87 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $1,299 | $42 |
| Aspiration and/or injection of fluid from large joint | 13 | $1,268 | $55 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 59 | $535 | None |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 63 | $73 | $0 |
| Injection, fentanyl citrate, 0.1 mg | 17 | $17 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 17 | $6 | None |
| Injection, midazolam hydrochloride, per 1 mg | 23 | $5 | None |
| Injection, propofol, 10 mg | 13 | $2 | None |
2019: 30 services
| Testing for presence of drug, by chemistry analyzers | 204 | $15,738 | $63 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 44 | $13,505 | $199 |
| Short return visit (20+ min) | 146 | $13,369 | $58 |
| Injection of substance into lower spine canal using imaging guidance | 38 | $12,931 | $202 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 83 | $10,328 | $111 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 56 | $10,322 | $150 |
| Return visit (30+ min) | 79 | $9,954 | $87 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 28 | $9,437 | $242 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 20 | $5,906 | $185 |
| New patient visit (45+ min) | 45 | $5,836 | $130 |
| Injection of trigger points, 3 or more muscles | 31 | $5,546 | $52 |
| Ultrasonic guidance for needle placement | 30 | $4,616 | $44 |
| New patient visit (45+ min) | 27 | $2,970 | $110 |
| Injection of substance into lower spine canal using imaging guidance | 20 | $2,904 | $85 |
| Fluoroscopic guidance for needle placement | 17 | $2,866 | $80 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 19 | $2,632 | $94 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 15 | $2,380 | $99 |
| Aspiration and/or injection of fluid from large joint | 17 | $2,121 | $59 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $1,993 | $41 |
| Return visit (30+ min) | 21 | $1,792 | $66 |
| Injection of trigger points, 3 or more muscles | 16 | $1,642 | $37 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 99 | $1,309 | None |
| Ultrasonic guidance for needle placement | 16 | $1,102 | $27 |
| Aspiration and/or injection of fluid from large joint | 12 | $1,006 | $42 |
| Fluoroscopic guidance for needle placement | 12 | $540 | $23 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 101 | $143 | $0 |
| Injection, fentanyl citrate, 0.1 mg | 22 | $23 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 29 | $16 | None |
| Injection, midazolam hydrochloride, per 1 mg | 27 | $8 | None |
| Injection, propofol, 10 mg | 20 | $5 | None |
2018: 32 services
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 54 | $17,606 | $200 |
| Testing for presence of drug, by chemistry analyzers | 193 | $16,704 | $69 |
| Short return visit (20+ min) | 112 | $14,080 | $57 |
| Return visit (30+ min) | 75 | $11,999 | $85 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 60 | $11,584 | $149 |
| Injection of substance into lower spine canal using imaging guidance | 34 | $9,468 | $206 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 76 | $9,210 | $111 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 27 | $8,711 | $242 |
| New patient visit (45+ min) | 44 | $6,082 | $138 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 18 | $5,710 | $197 |
| Injection of trigger points, 3 or more muscles | 20 | $3,908 | $54 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 21 | $3,680 | $99 |
| Ultrasonic guidance for needle placement | 19 | $3,486 | $49 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 44 | $3,290 | $43 |
| Fluoroscopic guidance for needle placement | 20 | $3,259 | $78 |
| Injection of substance into lower spine canal using imaging guidance | 24 | $3,103 | $82 |
| Injection of substance into middle or upper spine canal using imaging guidance | 13 | $2,720 | $194 |
| Aspiration and/or injection of fluid from large joint | 20 | $2,579 | $60 |
| New patient visit (30+ min) | 26 | $2,385 | $92 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 15 | $2,300 | $100 |
| New patient visit (45+ min) | 20 | $2,211 | $111 |
| Return visit (30+ min) | 18 | $1,456 | $66 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 102 | $1,294 | None |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 12 | $1,244 | $78 |
| Short return visit (20+ min) | 13 | $652 | $38 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $509 | $11 |
| Psychological testing with interpretation and report by computer | 12 | $304 | $23 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 105 | $155 | $0 |
| Injection, fentanyl citrate, 0.1 mg | 33 | $60 | None |
| Injection, propofol, 10 mg | 37 | $12 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 21 | $10 | None |
| Injection, midazolam hydrochloride, per 1 mg | 40 | $10 | None |
2017: 36 services
| Testing for presence of drug, by chemistry analyzers | 171 | $16,160 | $78 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 48 | $15,271 | $209 |
| Return visit (30+ min) | 110 | $12,782 | $84 |
| Short return visit (20+ min) | 117 | $11,183 | $56 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 34 | $10,947 | $249 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 76 | $9,455 | $115 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 50 | $8,856 | $155 |
| Injection of substance into lower spine canal using imaging guidance | 28 | $6,925 | $198 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 23 | $6,675 | $180 |
| New patient visit (45+ min) | 46 | $5,642 | $123 |
| Complete ultrasound study of arm and leg arteries | 15 | $3,572 | $115 |
| Injection of substance into middle or upper spine canal using imaging guidance | 13 | $3,373 | $211 |
| Injection of substance into lower spine canal using imaging guidance | 20 | $3,367 | $84 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 41 | $3,336 | $42 |
| New patient visit (45+ min) | 26 | $2,832 | $109 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 20 | $2,695 | $100 |
| New patient visit (30+ min) | 23 | $2,114 | $92 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 12 | $2,039 | $93 |
| Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | 15 | $1,919 | $128 |
| Short return visit (20+ min) | 35 | $1,899 | $42 |
| Testing of autonomic (sympathetic) nervous system function | 14 | $1,642 | $117 |
| Return visit (30+ min) | 22 | $1,432 | $55 |
| Injection of trigger points, 3 or more muscles | 15 | $1,382 | $51 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 95 | $1,359 | None |
| Ultrasonic guidance for needle placement | 15 | $1,281 | $47 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 13 | $1,253 | $74 |
| Aspiration and/or injection of fluid from large joint | 11 | $960 | $37 |
| Fluoroscopic guidance for needle placement | 11 | $526 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $340 | $10 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 15 | $164 | $11 |
| Testing for presence of drug, read by direct observation | 11 | $161 | $15 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 92 | $113 | $0 |
| Injection, fentanyl citrate, 0.1 mg | 30 | $21 | None |
| Injection, propofol, 10 mg | 35 | $11 | None |
| Injection, midazolam hydrochloride, per 1 mg | 40 | $10 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 16 | $7 | None |
2016: 31 services
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 61 | $19,384 | $186 |
| Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when | 192 | $18,794 | $78 |
| Short return visit (20+ min) | 155 | $15,505 | $59 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 46 | $14,976 | $211 |
| Return visit (30+ min) | 104 | $13,894 | $88 |
| Injections of substances into lower or sacral spine | 40 | $11,460 | $185 |
| New patient visit (45+ min) | 61 | $8,192 | $134 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 57 | $7,834 | $121 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 21 | $5,440 | $170 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 64 | $5,249 | $78 |
| New patient visit (30+ min) | 41 | $3,495 | $85 |
| Injections of substances into lower or sacral spine | 30 | $3,435 | $78 |
| Short return visit (20+ min) | 36 | $2,294 | $42 |
| New patient visit (45+ min) | 20 | $2,229 | $111 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 15 | $2,007 | $106 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 110 | $2,003 | None |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 50 | $1,882 | $21 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 18 | $1,711 | $74 |
| Return visit (30+ min) | 23 | $1,606 | $64 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $1,439 | $80 |
| Aspiration and/or injection of fluid from large joint | 11 | $1,238 | $43 |
| Injection of trigger points, 3 or more muscles | 12 | $999 | $53 |
| Ultrasonic guidance for needle placement | 12 | $990 | $49 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 27 | $972 | $21 |
| Fluoroscopic guidance for needle placement | 11 | $698 | $24 |
| Psychological testing with interpretation and report by computer | 26 | $658 | $23 |
| Psychological testing with interpretation and report by computer | 16 | $413 | $23 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 115 | $103 | $0 |
| Injection, propofol, 10 mg | 48 | $17 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 20 | $15 | None |
| Injection, midazolam hydrochloride, per 1 mg | 48 | $12 | None |
2015: 43 services
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 50 | $13,136 | $190 |
| Short return visit (20+ min) | 102 | $9,974 | $57 |
| Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter | 68 | $7,080 | $97 |
| Injections of substances into lower or sacral spine | 29 | $6,592 | $183 |
| Drug confirmation, each procedure | 44 | $5,319 | $18 |
| Return visit (30+ min) | 48 | $4,797 | $77 |
| Injections of substances into lower or sacral spine | 43 | $4,612 | $76 |
| New patient visit (45+ min) | 32 | $4,251 | $133 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 30 | $4,103 | $105 |
| Opiate(s), drug and metabolites, each procedure | 39 | $3,996 | $26 |
| New patient visit (30+ min) | 40 | $3,688 | $92 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $3,350 | $197 |
| Injections of substances into upper or middle spine | 11 | $3,016 | $201 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 11 | $2,528 | $194 |
| Short return visit (20+ min) | 48 | $2,467 | $37 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 12 | $2,246 | $150 |
| New patient visit (45+ min) | 18 | $2,013 | $112 |
| Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | 16 | $1,966 | $123 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $1,950 | $93 |
| New patient visit (30+ min) | 28 | $1,795 | $64 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 53 | $1,748 | $20 |
| Return visit (30+ min) | 23 | $1,724 | $66 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 88 | $1,320 | None |
| Aspiration and/or injection of fluid from large joint | 14 | $1,250 | $45 |
| Alkaloids, urine, quantitative | 30 | $997 | $29 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $980 | $52 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 11 | $950 | $68 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 32 | $904 | $21 |
| Meprobamate | 30 | $799 | $24 |
| Psychological testing with interpretation and report by computer | 28 | $702 | $21 |
| Benzodiazepines | 21 | $687 | $16 |
| Amitriptyline | 13 | $669 | $24 |
| Fluoroscopic guidance for needle placement | 15 | $658 | $24 |
| Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | 30 | $620 | $19 |
| Psychological testing with interpretation and report by computer | 26 | $619 | $19 |
| Barbiturates, not elsewhere specified | 11 | $366 | $15 |
| Desipramine | 13 | $321 | $23 |
| Assay of imipramine | 13 | $321 | $23 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 92 | $101 | $0 |
| Injection, propofol, 10 mg | 55 | $32 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 28 | $29 | None |
| Injection, midazolam hydrochloride, per 1 mg | 57 | $13 | None |
| Injection, fentanyl citrate, 0.1 mg | 16 | $7 | None |
2014: 40 services
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 65 | $20,932 | $207 |
| Return visit (30+ min) | 100 | $15,612 | $84 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 46 | $7,089 | $101 |
| Short return visit (20+ min) | 68 | $5,600 | $42 |
| New patient visit (45+ min) | 36 | $5,070 | $141 |
| Return visit (30+ min) | 52 | $4,988 | $66 |
| Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | 28 | $4,111 | $133 |
| Fluoroscopic guidance for spine or back muscle injection | 26 | $3,059 | $75 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 26 | $2,511 | $76 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 13 | $2,478 | $155 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $2,446 | $153 |
| Injections of substances into lower or sacral spine | 25 | $2,087 | $61 |
| New patient visit (30+ min) | 34 | $2,086 | $61 |
| Psychological testing with interpretation and report by computer | 69 | $2,080 | $22 |
| Injections of substances into lower or sacral spine | 16 | $2,002 | $91 |
| Injections of substances into upper or middle spine | 13 | $1,855 | $93 |
| Anesthesia for nerve block and injection procedure, prone position | 15 | $1,829 | $122 |
| New patient visit (45+ min) | 16 | $1,803 | $113 |
| Short return visit (20+ min) | 29 | $1,774 | $52 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 47 | $1,713 | $19 |
| Injection of trigger points, 3 or more muscles | 17 | $1,710 | $36 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,530 | $45 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 104 | $1,470 | None |
| Ultrasonic guidance for needle placement | 17 | $1,444 | $60 |
| Ultrasonic guidance for needle placement | 17 | $1,401 | $29 |
| Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | 63 | $1,400 | $19 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 11 | $1,323 | $95 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $1,185 | $79 |
| Fluoroscopic guidance for spine or back muscle injection | 30 | $1,106 | $26 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 18 | $1,034 | $41 |
| Injection of trigger points, 3 or more muscles | 17 | $1,005 | $46 |
| Fluoroscopic guidance for needle placement | 18 | $758 | $24 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 23 | $635 | $20 |
| Psychological testing with interpretation and report by computer | 25 | $631 | $22 |
| Short return visit | 14 | $325 | $22 |
| Unclassified drugs | 48 | $241 | None |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 98 | $68 | $0 |
| Injection, fentanyl citrate, 0.1 mg | 37 | $21 | None |
| Injection, midazolam hydrochloride, per 1 mg | 62 | $21 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 13 | $15 | None |
2013: 40 services
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 41 | $12,838 | $207 |
| Injections of substances into lower or sacral spine | 27 | $7,940 | $173 |
| Return visit (30+ min) | 44 | $7,922 | $84 |
| Return visit (30+ min) | 80 | $7,734 | $63 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 41 | $6,014 | $99 |
| New patient visit (45+ min) | 43 | $5,917 | $138 |
| Injections of substances into lower or sacral spine | 50 | $5,619 | $74 |
| Short return visit (20+ min) | 70 | $5,289 | $42 |
| New patient visit (45+ min) | 43 | $4,777 | $111 |
| Short return visit (20+ min) | 39 | $4,677 | $59 |
| Fluoroscopic guidance for spine or back muscle injection | 34 | $4,294 | $78 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 18 | $3,597 | $150 |
| Anesthesia for x-ray procedure (accessed through the skin) on spine and spinal cord | 26 | $3,400 | $126 |
| Psychological testing with interpretation and report by computer | 37 | $2,591 | $56 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 21 | $2,372 | $95 |
| Fluoroscopic guidance for spine or back muscle injection | 59 | $2,345 | $25 |
| Anesthesia for nerve block and injection procedure, prone position | 14 | $2,048 | $114 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 52 | $1,804 | $20 |
| Fluoroscopic guidance for needle placement | 11 | $1,771 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,581 | $83 |
| Short return visit | 29 | $1,488 | $35 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 86 | $1,426 | None |
| Injections of substances into upper or middle spine | 12 | $1,426 | $89 |
| Aspiration and/or injection of fluid from large joint | 11 | $1,381 | $60 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 13 | $1,306 | $77 |
| New patient visit (30+ min) | 20 | $1,304 | $65 |
| Injection of trigger points, 3 or more muscles | 11 | $1,203 | $34 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 12 | $1,172 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,131 | $60 |
| Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | 49 | $1,100 | $20 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 19 | $956 | $42 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 15 | $946 | $53 |
| Aspiration and/or injection of fluid from large joint | 15 | $936 | $45 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 22 | $591 | $20 |
| Fluoroscopic guidance for needle placement | 13 | $586 | $22 |
| Short return visit | 16 | $337 | $21 |
| Unclassified drugs | 12 | $328 | None |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 81 | $92 | $0 |
| Injection, fentanyl citrate, 0.1 mg | 31 | $26 | None |
| Injection, midazolam hydrochloride, per 1 mg | 36 | $15 | None |
Medicaid work
$105,586 in 2024
Medicaid paid $105,586 for 1,437 billed services this clinician did in 2024, up to 63 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 500 | $67,491 |
| Return visit (30+ min) | 545 | $19,981 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 54 | $11,811 |
| Supplies and materials (except spectacles), provided by the physician or other qualified health care professional over and above those usually included with the office visit or other services rendered (list drugs, trays, supplies, or materials provided) | 74 | $2,328 |
| 1ST HOSP IP/OBS SF/LOW 40 | 55 | $2,152 |
| Injection, midazolam hydrochloride, per 1 mg | 90 | $1,006 |
| Fentanyl citrate injection | 87 | $622 |
| New patient visit (45+ min) | 32 | $198 |
| 2024 | 1,437 | 8 | 63 | $105,586 |
| 2023 | 811 | 10 | 46 | $70,700 |
| 2022 | 60 | 1 | 41 | $7,964 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 418 | $54,261 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 42 | $9,004 |
| 1ST HOSP IP/OBS SF/LOW 40 | 55 | $2,047 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 29 | $2,013 |
| Lidocaine injection | 46 | $1,613 |
| Supplies and materials (except spectacles), provided by the physician or other qualified health care professional over and above those usually included with the office visit or other services rendered (list drugs, trays, supplies, or materials provided) | 36 | $751 |
| Injection, midazolam hydrochloride, per 1 mg | 48 | $422 |
| Fentanyl citrate injection | 47 | $340 |
| Return visit (30+ min) | 78 | $248 |
| New patient visit (45+ min) | 12 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 60 | $7,964 |
Drugs they prescribed that Part D paid
$11,395
Pharmacies billed $11,395 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 56% of their Part D prescriptions (64 of 115) in 2024. Above the middle of the specialty; the typical pain management clinician is at 44%. Long-acting opioids: 55% of their opioid prescriptions.
94 generic and 21 brand-name prescriptions · $11,395 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | 20 | $3,784 | $189 |
| Naloxone | 14 | $635 | $45 |
| Gabapentin | 14 | $164 | $12 |
| Hydrocodone-Acetaminophen | 13 | $95 | $7 |
Year by year
| 2024 | 115 | 44 | 56% (64) | 18% | $11,395 |
| 2023 | 51 | 23 | 39% (20) | None | $5,985 |
| 2022 | 11 | None | 0% (0) | 0% | $159 |
| 2021 | 24 | 12 | None | 0% | $458 |
| 2020 | 294 | 114 | 49% (143) | 4% | $6,956 |
| 2019 | 560 | 183 | 52% (291) | 10% | $32,879 |
| 2018 | 437 | 141 | 43% (187) | 8% | $24,236 |
| 2017 | 428 | 149 | 52% (221) | 10% | $33,543 |
| 2016 | 472 | 165 | 61% (289) | 15% | $35,607 |
| 2015 | 499 | 169 | 53% (265) | 14% | $32,115 |
| 2014 | 781 | 193 | 50% (387) | 19% | $70,566 |
| 2013 | 787 | 169 | 49% (386) | 26% | $65,931 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Buprenorphine | 11 | $3,637 | $331 |
2020: 6 drugs
| Gabapentin | 65 | $978 | $15 |
| Duloxetine | 17 | $896 | $53 |
| Hydrocodone-Acetaminophen | 83 | $882 | $11 |
| Oxycodone-Acetaminophen | 19 | $341 | $18 |
| Tizanidine | 23 | $326 | $14 |
| Tramadol | 20 | $77 | $4 |
2019: 9 drugs
| Lyrica | 15 | $9,877 | $658 |
| Oxycontin | 15 | $2,870 | $191 |
| Hydrocodone-Acetaminophen | 156 | $2,254 | $14 |
| Gabapentin | 119 | $2,242 | $19 |
| Oxycodone-Acetaminophen | 46 | $1,313 | $29 |
| Diclofenac | 16 | $846 | $53 |
| Duloxetine | 22 | $458 | $21 |
| Tizanidine | 29 | $374 | $13 |
| Tramadol | 42 | $156 | $4 |
2018: 9 drugs
| Lyrica | 17 | $8,988 | $529 |
| Gabapentin | 107 | $1,976 | $18 |
| Hydrocodone-Acetaminophen | 111 | $1,917 | $17 |
| Diclofenac | 13 | $1,072 | $82 |
| Duloxetine | 23 | $674 | $29 |
| Oxycodone-Acetaminophen | 34 | $653 | $19 |
| Tizanidine | 21 | $275 | $13 |
| Tramadol | 18 | $90 | $5 |
| Cyclobenzaprine | 11 | $87 | $8 |
2017: 9 drugs
| Lyrica | 13 | $6,348 | $488 |
| Hydrocodone-Acetaminophen | 114 | $1,708 | $15 |
| Gabapentin | 94 | $1,676 | $18 |
| Oxycodone-Acetaminophen | 37 | $1,173 | $32 |
| Duloxetine | 15 | $482 | $32 |
| Tizanidine | 15 | $222 | $15 |
| Tramadol | 28 | $151 | $5 |
| Acetaminophen-Codeine | 15 | $128 | $9 |
| Cyclobenzaprine | 13 | $58 | $4 |
2016: 10 drugs
| Lyrica | 20 | $10,137 | $507 |
| Butrans | 15 | $6,287 | $419 |
| Opana Er | 12 | $4,975 | $415 |
| Hydrocodone-Acetaminophen | 148 | $2,767 | $19 |
| Oxycodone-Acetaminophen | 43 | $2,219 | $52 |
| Gabapentin | 61 | $1,150 | $19 |
| Duloxetine | 20 | $740 | $37 |
| Tramadol | 35 | $364 | $10 |
| Tizanidine | 23 | $255 | $11 |
| Acetaminophen-Codeine | 17 | $198 | $12 |
2015: 10 drugs
| Lyrica | 13 | $4,812 | $370 |
| Oxycontin | 16 | $4,684 | $293 |
| Gabapentin | 101 | $2,726 | $27 |
| Hydrocodone-Acetaminophen | 115 | $2,528 | $22 |
| Oxycodone-Acetaminophen | 44 | $2,149 | $49 |
| Tizanidine | 23 | $1,274 | $55 |
| Duloxetine | 17 | $983 | $58 |
| Voltaren | 14 | $764 | $55 |
| Tramadol | 41 | $293 | $7 |
| Acetaminophen-Codeine | 13 | $153 | $12 |
2014: 14 drugs
| Lyrica | 35 | $11,423 | $326 |
| Oxycontin | 36 | $11,296 | $314 |
| Duloxetine | 58 | $10,755 | $185 |
| Lidoderm | 11 | $8,086 | $735 |
| Gabapentin | 167 | $4,212 | $25 |
| Hydrocodone-Acetaminophen | 176 | $3,714 | $21 |
| Lidocaine | 11 | $3,479 | $316 |
| Oxycodone-Acetaminophen | 44 | $2,630 | $60 |
| Butrans | 11 | $2,444 | $222 |
| Fentanyl | 21 | $1,762 | $84 |
| Voltaren | 25 | $1,276 | $51 |
| Morphine Sulfate Er | 12 | $675 | $56 |
| Tizanidine | 21 | $542 | $26 |
| Tramadol | 66 | $507 | $8 |
2013: 16 drugs
| Cymbalta | 73 | $18,676 | $256 |
| Lyrica | 40 | $12,051 | $301 |
| Lidoderm | 12 | $8,554 | $713 |
| Gabapentin | 164 | $5,023 | $31 |
| Oxycontin | 23 | $4,738 | $206 |
| Hydrocodone-Acetaminophen | 185 | $4,130 | $22 |
| Fentanyl | 20 | $2,307 | $115 |
| Oxycodone Hcl-Acetaminophen | 18 | $911 | $51 |
| Voltaren | 16 | $789 | $49 |
| Morphine Sulfate Er | 26 | $687 | $26 |
| Tramadol | 61 | $593 | $10 |
| Tizanidine | 15 | $432 | $29 |
| Oxycodone-Acetaminophen | 14 | $327 | $23 |
| Cyclobenzaprine | 14 | $293 | $21 |
| Oxycodone | 12 | $279 | $23 |
| Methadone | 11 | $102 | $9 |
Money from drug and device companies
$390 in 2025
| 2025 | 2 | 7 | None | $390 |
| 2024 | 2 | 6 | None | $581 |
| 2023 | 3 | 5 | None | $356 |
| 2020 | 8 | 10 | None | $173 |
| 2019 | 15 | 37 | None | $691 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Proclaim | $337 | 5 payments
|
| Abbvie | Botox | $54 | 2 payments
|
See all 7 published payments
| Abbott Laboratories | Meals · 2025-12-01 | Proclaim | $161 |
| Abbott Laboratories | Meals · 2025-10-31 | Eterna | $7 |
| Abbott Laboratories | Meals · 2025-07-29 | Proclaim | $30 |
| Abbott Laboratories | Meals · 2025-07-21 | Proclaim | $116 |
| Abbott Laboratories | Meals · 2025-05-20 | Proclaim | $24 |
| Abbvie | Meals · 2025-05-08 | Botox | $32 |
| Abbvie | Meals · 2025-03-19 | Botox | $22 |
See earlier years (2024, 2023, 2020, 2019)
2024: $581
| Abbott Laboratories | Proclaim | $557 | 5 payments
|
| Pacira Pharmaceuticals | Iovera | $24 | 1 payment
|
2023: $356
| Abbott Laboratories | Proclaim | $319 | 3 payments
|
| Vertos Medical | Mild Device Kit | $21 | 1 payment
|
| DePuy Synthes Sales | Orthovisc | $17 | 1 payment
|
2020: $173
| Allergan | Ubrelvy | $41 | 2 payments
|
| Fidia Pharma USA | Hymovis | $29 | 2 payments
|
| Lilly USA | Emgality | $20 | 1 payment
|
| Flexion Therapeutics | Zilretta | $20 | 1 payment
|
| Boston Scientific | Spectra Wavewriter | $18 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $17 | 1 payment
|
| US WorldMeds | Myobloc | $16 | 1 payment
|
| Zyla Life Sciences | Sprix | $12 | 1 payment
|
2019: $691
| Lilly USA | Emgality | $146 | 7 payments
|
| Collegium Pharmaceutical | Xtampza | $100 | 6 payments
|
| Boston Scientific | Spectra Wavewriter | $84 | 4 payments
|
| Teva Pharmaceuticals USA | Ajovy | $65 | 5 payments
|
| Nevro | Senza Spinal Cord Stimulation System | $58 | 3 payments
|
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $46 | 1 payment
|
| Scilex Pharmaceuticals | Ztlido 30 Pouch in 1 Carton 1 Patch in 1 Pouch | $43 | 2 payments
|
| Medtronic USA | Intellis | $26 | 1 payment
|
| Si-Bone | Ifuse Implant | $25 | 1 payment
|
| Arbor Pharmaceuticals | Horizant | $25 | 2 payments
|
| Vertiflex | Superion Iss | $17 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $16 | 1 payment
|
| Flexion Therapeutics | Zilretta | $14 | 1 payment
|
| Pfizer | Lyrica | $14 | 1 payment
|
| Assertio Therapeutics | Gralise | $11 | 1 payment
|
Professional record
- NPI
- 1750442422
- Licence
- CA C171447, IL 036122789, PA MT186102California C171447: Current · expires 2027-02-28Illinois 036122789: Active
- Trained
- Medical College of Wisconsin, 2004 · 22 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- IL 036122789
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 207L00000X (207L00000X)
- Mailing address
- 1365 Wiley Road, Suite 153, Schaumburg, IL, 60173
- NPI first listed
- 2006-12-13
- NPI last updated
- 2022-10-10
- NPI record certified
- 2022-10-10
This is when the NPI record was last certified, not a medical board exam.